2026 Q2 -tulosraportti
Vain PDF
10 päivää sitten
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 898 | NRD | NON | ||
| 851 | NRD | NON | ||
| 741 | NRD | NON | ||
| 84 | NON | NON | ||
| 425 | NON | NON |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 26.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 28.8. | ||
2026 Q1 -tulosraportti 28.5. | ||
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 13.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·2 päivää sittenTwo things: the number of traded shares is extremely low at the moment - e.g. for today it is approx. 2,500. The number of owners on Nordnet is at its highest! Despite EMA defeat, and poor communication, people are not abandoning the stock.
Negative, that it trades so little. It's an expression that interest in the stock is weak. Even 28aug vol was only 150k. I mean.. On launch. What everyone "has been waiting for" since early spring. It rises a measly 20% on a moderately satisfied volume. Extremely negative. Number of owners on Nordnet says absolutely nothing other than that a rotation has occurred best case, worst case investors of relevance have left the stock with large holdings and it is now spread out over the next team of fortune seekers, who unfortunately probably came too late to the party. Fair enough there are 2024-or earlier people who haven't sold a single stock (maybe...), that's probably true. But unfortunately, I think you have to expect that there are more of the old guard who are currently signaling and have signaled pass for some time. There's simply too much mess in the case currently, for 8-10 kr to feel interesting. So we are dealing with people who came late for whom 10 kr represents "buy the dip"... that's up to them to believe. Personally, I think it will be half that in 4-5 weeks. But everyone naturally does their own DD and invests accordingly. Regards an old cessa guy who hasn't really been able to find the spirit in 2026 to step in again. Luckily for that, given how it has gone.
·2.9.Summarizes the status and Cessatech's complex situation really well regarding the US launch and (for now) the rejection from EMA. Can they use data from the USA to get EMA's decision overturned later in the year? What does the panel here say? https://www.linkedin.com/posts/marketaccess-share-7500132724192567296-ocWy/
In light of the EMA rejection, Cessatech could also focus on the British market, if they aren't already doing this? They do have the partnership with Proveca, which resides in England and can drive the process. As I understand it, the approval from the American early access programme can precisely be used to accelerate a procedure through the Medicines and Healthcare products Regulatory Agency in England (MHRA) where one can utilize the American data. Furthermore, parts of the clinical studies have been conducted in English hospitals, which should, all things considered, provide a good data basis for the British authorities.
·1.9.STAQ is ready to sell and, popularly speaking, has some stock ready, but has the FDA released the product? There was something about some product evaluation and quality assurance that needs to be in place before the product may be sold.
It's so ridiculous that it's about their packaging not being secure enough regarding opening it….
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 -tulosraportti
Vain PDF
10 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 päivää sittenTwo things: the number of traded shares is extremely low at the moment - e.g. for today it is approx. 2,500. The number of owners on Nordnet is at its highest! Despite EMA defeat, and poor communication, people are not abandoning the stock.Negative, that it trades so little. It's an expression that interest in the stock is weak. Even 28aug vol was only 150k. I mean.. On launch. What everyone "has been waiting for" since early spring. It rises a measly 20% on a moderately satisfied volume. Extremely negative. Number of owners on Nordnet says absolutely nothing other than that a rotation has occurred best case, worst case investors of relevance have left the stock with large holdings and it is now spread out over the next team of fortune seekers, who unfortunately probably came too late to the party. Fair enough there are 2024-or earlier people who haven't sold a single stock (maybe...), that's probably true. But unfortunately, I think you have to expect that there are more of the old guard who are currently signaling and have signaled pass for some time. There's simply too much mess in the case currently, for 8-10 kr to feel interesting. So we are dealing with people who came late for whom 10 kr represents "buy the dip"... that's up to them to believe. Personally, I think it will be half that in 4-5 weeks. But everyone naturally does their own DD and invests accordingly. Regards an old cessa guy who hasn't really been able to find the spirit in 2026 to step in again. Luckily for that, given how it has gone.
- ·2.9.Summarizes the status and Cessatech's complex situation really well regarding the US launch and (for now) the rejection from EMA. Can they use data from the USA to get EMA's decision overturned later in the year? What does the panel here say? https://www.linkedin.com/posts/marketaccess-share-7500132724192567296-ocWy/In light of the EMA rejection, Cessatech could also focus on the British market, if they aren't already doing this? They do have the partnership with Proveca, which resides in England and can drive the process. As I understand it, the approval from the American early access programme can precisely be used to accelerate a procedure through the Medicines and Healthcare products Regulatory Agency in England (MHRA) where one can utilize the American data. Furthermore, parts of the clinical studies have been conducted in English hospitals, which should, all things considered, provide a good data basis for the British authorities.
- ·1.9.STAQ is ready to sell and, popularly speaking, has some stock ready, but has the FDA released the product? There was something about some product evaluation and quality assurance that needs to be in place before the product may be sold.It's so ridiculous that it's about their packaging not being secure enough regarding opening it….
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 898 | NRD | NON | ||
| 851 | NRD | NON | ||
| 741 | NRD | NON | ||
| 84 | NON | NON | ||
| 425 | NON | NON |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 26.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 28.8. | ||
2026 Q1 -tulosraportti 28.5. | ||
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 13.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 -tulosraportti
Vain PDF
10 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 26.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 28.8. | ||
2026 Q1 -tulosraportti 28.5. | ||
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 13.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 päivää sittenTwo things: the number of traded shares is extremely low at the moment - e.g. for today it is approx. 2,500. The number of owners on Nordnet is at its highest! Despite EMA defeat, and poor communication, people are not abandoning the stock.Negative, that it trades so little. It's an expression that interest in the stock is weak. Even 28aug vol was only 150k. I mean.. On launch. What everyone "has been waiting for" since early spring. It rises a measly 20% on a moderately satisfied volume. Extremely negative. Number of owners on Nordnet says absolutely nothing other than that a rotation has occurred best case, worst case investors of relevance have left the stock with large holdings and it is now spread out over the next team of fortune seekers, who unfortunately probably came too late to the party. Fair enough there are 2024-or earlier people who haven't sold a single stock (maybe...), that's probably true. But unfortunately, I think you have to expect that there are more of the old guard who are currently signaling and have signaled pass for some time. There's simply too much mess in the case currently, for 8-10 kr to feel interesting. So we are dealing with people who came late for whom 10 kr represents "buy the dip"... that's up to them to believe. Personally, I think it will be half that in 4-5 weeks. But everyone naturally does their own DD and invests accordingly. Regards an old cessa guy who hasn't really been able to find the spirit in 2026 to step in again. Luckily for that, given how it has gone.
- ·2.9.Summarizes the status and Cessatech's complex situation really well regarding the US launch and (for now) the rejection from EMA. Can they use data from the USA to get EMA's decision overturned later in the year? What does the panel here say? https://www.linkedin.com/posts/marketaccess-share-7500132724192567296-ocWy/In light of the EMA rejection, Cessatech could also focus on the British market, if they aren't already doing this? They do have the partnership with Proveca, which resides in England and can drive the process. As I understand it, the approval from the American early access programme can precisely be used to accelerate a procedure through the Medicines and Healthcare products Regulatory Agency in England (MHRA) where one can utilize the American data. Furthermore, parts of the clinical studies have been conducted in English hospitals, which should, all things considered, provide a good data basis for the British authorities.
- ·1.9.STAQ is ready to sell and, popularly speaking, has some stock ready, but has the FDA released the product? There was something about some product evaluation and quality assurance that needs to be in place before the product may be sold.It's so ridiculous that it's about their packaging not being secure enough regarding opening it….
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 898 | NRD | NON | ||
| 851 | NRD | NON | ||
| 741 | NRD | NON | ||
| 84 | NON | NON | ||
| 425 | NON | NON |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt